Press Releases :: Rigel Pharmaceuticals, Inc. (RIGL)

Jul 08, 2009 9:00pm EDT

Rigel to Host Conference Call to Discuss Results of Its Phase 2b TASKi2 Clinical Trial of R788 in Rheumatoid Arthritis

Jun 10, 2009 7:30am EDT

Rigel to Present at Jefferies Healthcare Conference

Jun 01, 2009 7:30am EDT

Rigel's R788 Evaluated in Phase 2 Trial in Multiple Cancers

May 13, 2009 7:30am EDT

Rigel to Present at JMP Securities Research Conference

May 05, 2009 7:00am EDT

Rigel Announces First Quarter 2009 Financial Results

Feb 24, 2009 6:00am EST

Rigel Announces Fourth Quarter and Year End 2008 Financial Results

Feb 05, 2009 7:30am EST

Rigel to Present at BIO CEO & Investor Conference

Feb 03, 2009 6:00am EST

Rigel Expects R788 Partnership After Phase 2b Clinical Trials Results

Feb 02, 2009 6:00pm EST

Rigel to Host Conference Call on February 3, 2009

Jan 23, 2009 7:30am EST

Rigel to Present at Keystone Symposia Conference